Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Some BPC-157 users opt for oral administration, though injectable forms are generally considered to provide more predictable results for localized injuries like shoulder conditions
Skin quality improvements may become apparent
Bisher gibt es nur 3 Pilotstudien mit Menschen: 2025 - Intravense Sicherheitsstudie: Eine sehr kleine Studie mit nur 2 Erwachsenen testete die intravense Verabreichung von BPC-157 in Dosen bis zu 20 mg
Available in lyophilized powder form
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
As qualified research buyers place greater weight on lot-specific documentation in 2026, this Sourced Peptides BPC-157 review examines the linked 5mg COA, reported 99.703% purity result, current vial and bundle options, and the verification steps serious laboratories should complete before ordering
